Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Ucsf Cancer Center and Cancer Research Institute
San Francisco, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Pediatric Oncology Branch
Bethesda, Maryland, United States
- Cleveland Clinic Cancer Center
Cleveland, Ohio, United States
- Texas Children'S Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 1998
- Primary completion
- —
- Completion
- 30 Sept 2004
- Last update posted
- 26 Jun 2013
- Registered enrollment
- —
- Registry id
- NCT00003241
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.